SII

The Serum Institute of India, the world’s largest vaccine manufacturer, is expecting to launch another COVID-19 vaccine called Covovax by June, the company’s CEO Adar Poonawalla said on Saturday. The …

Free Fire has a wide variety of in-game cosmetic items like costumes, emotes and more. Most of these items can be obtained using diamonds, one of the currencies in the …

Five men died in the fire that broke out in a five-storeyed under-construction building in the SII’s Manjari premises in Pune on Thursday File image of Uddhav Thackeray. Twitter@OfficeofUT Pune: …

It is learnt that two million doses each will be sent as commercial supplies to Brazil and Morocco, while a consignment of 1.5 million doses of Covishield will be delivered …

Fire at Serum Institute of India LIVE Updates: Five persons were killed in a blaze that broke out today afternoon at SII plant in Pune’s Manjari area. Maharshtra chief minister …

The Union Health Ministry announced Tuesday all vaccine doses, 1.10 crore from Serum Insititute of India and 55 lakh from Bharat Biotech, will be given to all states and Union …

Doses of the vaccine, Covishield, will initially be shipped to 60 consignee points and will then be distributed to various vaccination centres across India Representational image. PTI New Delhi: The …

A day before chief ministers’ interaction with Prime Minister Narendra Modi, several states on Sunday said they have made all necessary preparations for the first phase of nationwide roll-out of …

The verbal duel between the chiefs of Bharat Biotech and Serum Institute of India took place after the DCGI announced the approval of the Covaxin and Covishield vaccines Representational image. …

The Serum Institute of India (SII) clarified on Monday that the company is yet to receive the permission from the authority here to export its Covid-19 vaccine to other nations, …

Mumbai: The vaccination drive for the recently approved coronavirus vaccine can start in the country from this month. On Sunday, Drug Controller General of India (DCGI) VG Somani approved Serum …

India’s drugs regulator has given final emergency-use approval for two coronavirus vaccines — Serum Institute of India’s Covishield, developed by Oxford University and pharma major AstraZeneca, and Bharat Biotech’s Covaxin. …

India’s Subject Expert Committee (SEC) in Central Drugs Standard Control Organisation (CDSCO) met on Wednesday to consider coronavirus vaccines for emergency use authorisation (EUA) requested by Pfizer-BioNTech, Bharat Biotech and …

Last month, SII had rejected allegations of serious side-effects made by a participant in the Covishield vaccine trial in Chennai. The man had also sought Rs 5 crore compensation Adar …

The Serum Institute of India (SII) CEO Adar Poonawalla informed that the COVID-19 vaccination in India is likely to start by January 2021. He further said that his company is …

In a major development related to COVID-19 vaccine, Subject Expert Committee (SEC) of Drugs Controller General of India (DCGI) has asked for more safety and efficacy data from Serum Institute …

Last week, Prime Minister Narendra Modi had said that a COVID-19 vaccine ‘may be ready in a few weeks’ at an all-party meeting COVAXIN vaccine by Bharath Biotech. New Delhi: After …

Stressing that the Covishield vaccine is “safe and immunogenic”, the Serum Institute of India (SII) on Tuesday said the incident with the Chennai volunteer was in no way induced by …

A 40-year-old man who took part in the ‘Covishield’ vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions and has …

The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in about two weeks. Adar Poonawalla, Founder and CEO, SII said on Saturday …